echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > A batch of drugs to reduce prices: amoxilin, metformin...

    A batch of drugs to reduce prices: amoxilin, metformin...

    • Last Update: 2020-10-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Another batch of drugs, pharmacies will be big price reductions: amoxilin, metformin... It is important to note that if your area belongs to Guangdong and intends to participate, please fill in the pre-purchase quantity of the relevant medicines by 17:30 p.m. on July 3.
    The third batch of reduced-price drugs is announced, single drugstores may also participate in the third batch of national drug centralized procurement according to the Guangdong Provincial Medical Insurance Bureau "on the filling of the third batch of state-organized drugs centralized procurement of related drug medical institutions pre-procurement notice", fixed-point private medical institutions and fixed-point retail pharmacies may voluntarily participate in the third batch of centralized procurement of national drugs.
    recently, Guangdong Province has launched the third batch of national mining.
    the regulations, retail pharmacies, if involved, must fill in the provincial platform for the next year's pre-purchase of related drugs, and by 17:30 p.m. on July 3, 2020.
    need to be reminded that retail pharmacies in the provincial platform already have a registered account can be directly logged in to the operation, if not registered in the provincial platform, according to the process of registration can be.
    , this collection, drugstore chains, monosome pharmacies, pharmaceutical e-commerce enterprises can participate.
    , the chain drugstore directly by the headquarters for registration work, single drugstore by the store self-registration.
    chain, single drugstore to submit the following materials as follows: the national collection of Chinese medicine, pharmacies have begun to sell a few months ago, the second batch of collection varieties in Guangdong Province landed.
    Among them, Dasanlin, Nepta Xingchen and other chains to purchase a price-cutting drug, the original price of 65 yuan per box of imported raw research drug bai sugar flat (specs: 50mg x 30 tablets), currently in Guangdong pharmacies only 8.9 yuan per box ... It is understood that the first round of retail drug collection in Guangdong Province involved a total of 22 product regulations, the total purchase amount of more than 110 million yuan, a number of manufacturers to "4 plus 7" with the volume of procurement of the winning bid price is even lower than the winning bid price to Guangdong retail pharmacies, the average price drop of 61.2%.
    , in the first round of retail drug collection in Guangdong Province, nearly 170 drugstore chains, 400 single pharmacies, nearly 10,000 stores signed up to participate.
    , there are many pharmacies elsewhere that are selling nationally selected medicines.
    account special contributor Shi Xiaoqing told the author, "At present, some retail pharmacies in Shandong Province have carried out collection, retail pharmacies in coastal areas to do a better job of collection, the rest of the region is also slowly deploying work, it is expected that by the end of this year all pharmacies to collect."
    " to participate in the collection, good all pharmacies in Guangdong according to the results of the national drug centralized procurement, Bayer production of Bayer sugar flat supply provinces involving Beijing, Tianjin, Shanxi, Shandong, Henan, Hunan, Guangdong and other places, the specifications of 50mg x 30 pieces of the selected price (yuan) for 5.42 yuan / box.
    the retail price of 8.9 yuan per box in Guangdong Province, the increase is as high as 64%, and the gross profit of pharmacies is nearly 40%.
    in Guangdong run drugstores in the industry told the author, in the past to sell this medicine, basically do not earn any money.
    now 5 more purchases, selling 8.9 yuan, and still have to earn.
    , he said, not only did the profits of pharmacies not compress, but they also increased.
    And, this price reduction, the most beneficial is the chain, if a large chain needs to buy 16,000 boxes, the capital to 800,000 yuan, but now as long as about 80,000 yuan, leaving nearly 700,000 liquidity, this money can bring a lot of things to the enterprise.
    , Shi Xiaoqing also talked about drugstores to participate in the collection, procurement of drug quality is more secure, procurement has a certain range is also more convenient procurement.
    She believes that with a unified procurement catalog, which would lead to a more standardized drug procurement process and no longer have the same purposeless procurement of medicines as before, retail pharmacies would only need to choose from a centralized drug catalog.
    " itself retail pharmacy purchase channels are relatively narrow, some drugs are not good to enter, some companies do not distribute, so that will greatly solve these problems.
    "She added, "From the third batch of collection catalog, the variety of drugs and medical institutions need the drug varieties are basically the same, that is to say, later in the hospital can buy drugs, in the pharmacy can also be bought, after the patient to buy drugs is more convenient."
    " In addition, it should be noted that, at present, Jiangsu, Zhejiang, Yunnan, Xinjiang and many other places have talked about the sale of Chinese medicine in pharmacies, on the basis of the selected price, the maximum price increase of 15%.
    from the guangdong retail market feedback, there is no such provision.
    For example, in Dasanlin and Nepta Star Bai sugar flat (specs: 50mg x 30 pieces) retail price of 8.9 yuan / box, if in accordance with the maximum price increase of 15%, the maximum sugar flat can only sell 6.233 yuan.
    , Guangdong Province does not provide, which also gives retail pharmacies a lot of space, and the sale of Chinese medicine, profits are relatively high.
    : List of the third batch of collected varieties.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.